Literature DB >> 24100354

Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure.

Karl Y Bilimoria1, Jeanette Chung, Mila H Ju, Elliott R Haut, David J Bentrem, Clifford Y Ko, David W Baker.   

Abstract

IMPORTANCE: Postoperative venous thromboembolism (VTE) rates are widely reported quality metrics soon to be used in pay-for-performance programs. Surveillance bias occurs when some clinicians use imaging studies to detect VTE more frequently than other clinicians. Because they look more, they find more VTE events, paradoxically worsening their hospital's VTE quality measure performance. A surveillance bias may influence VTE measurement if (1) greater hospital VTE prophylaxis adherence fails to result in lower measured VTE rates, (2) hospitals with characteristics suggestive of higher quality (eg, more accreditations) have greater VTE prophylaxis adherence rates but worse VTE event rates, and (3) higher hospital VTE imaging utilization use rates are associated with higher measured VTE event rates.
OBJECTIVE: To examine whether a surveillance bias influences the validity of reported VTE rates. DESIGN, SETTING, AND PARTICIPANTS: 2010 Hospital Compare and American Hospital Association data from 2838 hospitals were merged. Next, 2009-2010 Medicare claims data for 954,926 surgical patient discharges from 2786 hospitals who were undergoing 1 of 11 major operations were used to calculate VTE imaging (duplex ultrasonography, chest computed tomography/magnetic resonance imaging, and ventilation-perfusion scans) and VTE event rates. MAIN OUTCOMES AND MEASURES: The association between hospital VTE prophylaxis adherence and risk-adjusted VTE event rates was examined. The relationship between a summary score of hospital structural characteristics reflecting quality (hospital size, numbers of accreditations/quality initiatives) and performance on VTE prophylaxis and risk-adjusted VTE measures was examined. Hospital-level VTE event rates were compared across VTE diagnostic imaging rate quartiles and with a quantile regression.
RESULTS: Greater hospital VTE prophylaxis adherence rates were weakly associated with worse risk-adjusted VTE event rates (r2 = 4.2%; P = .03). Hospitals with increasing structural quality scores had higher VTE prophylaxis adherence rates (93.3% vs 95.5%, lowest vs highest quality quartile; P < .001) but worse risk-adjusted VTE rates (4.8 vs 6.4 per 1000, lowest vs highest quality quartile; P < .001). Mean VTE diagnostic imaging rates ranged from 32 studies per 1000 in the lowest imaging use quartile to 167 per 1000 in the highest quartile (P < .001). Risk-adjusted VTE rates increased significantly with VTE imaging use rates in a stepwise fashion, from 5.0 per 1000 in the lowest quartile to 13.5 per 1000 in the highest quartile (P < .001). CONCLUSIONS AND RELEVANCE: Hospitals with higher quality scores had higher VTE prophylaxis rates but worse risk-adjusted VTE rates. Increased hospital VTE event rates were associated with increasing hospital VTE imaging use rates. Surveillance bias limits the usefulness of the VTE quality measure for hospitals working to improve quality and patients seeking to identify a high-quality hospital.

Entities:  

Mesh:

Year:  2013        PMID: 24100354     DOI: 10.1001/jama.2013.280048

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  41 in total

1.  Design and Implementation of a Comprehensive Surveillance System for Venous Thromboembolism in a Defined Region Using Electronic and Manual Approaches.

Authors:  Thomas L Ortel; Katie Arnold; Michele Beckman; Audrey Brown; Nimia Reyes; Ibrahim Saber; Ryan Schulteis; Bhavana Pendurthi Singh; Andrea Sitlinger; Elizabeth H Thames
Journal:  Appl Clin Inform       Date:  2019-07-31       Impact factor: 2.342

2.  When is It Safe to Start VTE Prophylaxis After Blunt Solid Organ Injury? A Prospective Study from a Level I Trauma Center.

Authors:  Morgan Schellenberg; Kenji Inaba; Subarna Biswas; Patrick Heindel; Elizabeth Benjamin; Aaron Strumwasser; Kazuhide Matsushima; Lydia Lam; Demetrios Demetriades
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352

Review 3.  ICU director data: using data to assess value, inform local change, and relate to the external world.

Authors:  David J Murphy; Ogbonna C Ogbu; Craig M Coopersmith
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

4.  Initial Public Reporting of Quality at Veterans Affairs vs Non-Veterans Affairs Hospitals.

Authors:  Eddie Blay; John Oliver DeLancey; D Brock Hewitt; Jeanette W Chung; Karl Y Bilimoria
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873

5.  Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.

Authors:  Sheng-Hsuan Chien; Chia-Jen Liu; Ying-Chung Hong; Chung-Jen Teng; Yu-Wen Hu; Fan-Chen Ku; Chiu-Mei Yeh; Tzeon-Jye Chiou; Jyh-Pyng Gau; Cheng-Hwai Tzeng
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-14       Impact factor: 4.553

6.  Post-Hospital Discharge Venous Thromboembolism in Colorectal Surgery.

Authors:  Zhobin Moghadamyeghaneh; Reza Fazl Alizadeh; Mark H Hanna; Grace Hwang; Joseph C Carmichael; Steven Mills; Alessio Pigazzi; Michael J Stamos
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

7.  Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.

Authors:  Margaret C Fang; Dongjie Fan; Sue Hee Sung; Daniel M Witt; John R Schmelzer; Steven R Steinhubl; Steven H Yale; Alan S Go
Journal:  Med Care       Date:  2017-12       Impact factor: 2.983

8.  Readmission rates due to venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review.

Authors:  Christine Klimowicz White; Jessica Langholtz; Zackory T Burns; Susan Kruse; Kimberly Sallee; David H Henry
Journal:  Support Care Cancer       Date:  2014-09-27       Impact factor: 3.603

9.  Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease.

Authors:  Kristopher T Kimmell; Kevin A Walter
Journal:  J Neurooncol       Date:  2014-08-23       Impact factor: 4.130

10.  Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009).

Authors:  Wei Huang; Robert J Goldberg; Frederick A Anderson; Catarina I Kiefe; Frederick A Spencer
Journal:  Am J Med       Date:  2014-05-06       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.